Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic | Nature Reviews Nephrology
Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease
Pathways: ACE Inhibitor Pathway | www.antibodies-online.com
Figure 1 | Renin-Angiotensin System and Sympathetic Neurotransmitter Release in the Central Nervous System of Hypertension
The usefulness of angiotensin-(1-7) and des-Arg9-bradykinin as novel biomarkers for metabolic syndrome | Hypertension Research
The alternative renin-angiotensin-system (RAS) signalling pathway in prostate cancer and its link to the current COVID-19 pandemic | SpringerLink
COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease - ScienceDirect
JCM | Free Full-Text | Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options
ACE2 as therapy for pulmonary arterial hypertension: the good outweighs the bad | European Respiratory Society
The Angiotensin-converting Enzyme Insertion/Deletion Polymorphism as a Common Risk Factor for Major Pregnancy Complications | In Vivo
IJMS | Free Full-Text | Treatment with Angiotensin-(1-7) Prevents Development of Oral Papilloma Induced in K-ras Transgenic Mice
Targeting the renin−angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges | PNAS
The renin-angiotensin system and specifically angiotensin-converting enzyme 2 as a potential therapeutic target in SARS-CoV-2 infections | SpringerLink
High glucose activates the alternative ACE2/Ang‑(1‑7)/Mas and APN/Ang IV/IRAP RAS axes in pancreatic β‑cells
Frontiers | When Less or More Isn't Enough: Renal Maldevelopment Arising From Disequilibrium in the Renin-Angiotensin System
JCI - The renin-angiotensin system: it's all in your head
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 | Critical Care | Full Text
Manipulation of the Renin-Angiotensin System | Circulation
Dysregulation of the placental renin–angiotensin system in human fetal growth restriction in: Reproduction Volume 158 Issue 3 (2019)
Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy | Science Translational Medicine
Frontiers | Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
JCI - The plasma kallikrein-kinin system counterbalances the renin-angiotensin system
ACE2 and COVID-19 and the resulting ARDS | Postgraduate Medical Journal
The Angiotensin-converting Enzyme Insertion/Deletion Polymorphism as a Common Risk Factor for Major Pregnancy Complications | In Vivo
